may 22 semaglutide On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding Semaglutide: Compounding pharmacies to end

This hormone helps regulate blood sugar levels and signals your brain when youre full

Heres a breakdown of the medication with some of the most frequent questions

Keep the pen in place for 5 to 10 seconds to ensure the full dose is delivered

The FDA has distinguished between mass-marketed compounded products and patient-specific compounding performed under Section 503A of the FD&C Act, which may remain permissible in narrow circumstances where a patient's medical needs cannot be met by an FDA-approved drug

KFF found that Medicare Advantage plans made 52.8 million prior authorization determinations in 2024, with 7.7% fully or partly denied

Metformin is also a diabetes medication that may cause weight loss, but it belongs to a different drug class than Ozempic